Basit öğe kaydını göster

dc.contributor.authorAtilla, Erden
dc.date.accessioned2020-11-20T08:07:38Z
dc.date.available2020-11-20T08:07:38Z
dc.date.issued2019
dc.identifier.urihttps://doi.org/10.5152/tjg.2018.18156tr_TR
dc.identifier.urihttp://hdl.handle.net/20.500.12575/72476
dc.description.abstractThe gastrointestinal (GI) system is one of the most commonly affected sites during a hematopoietic stem cell transplantation (HSCT) due to toxicities of preparative regimens, the accompanying immunodeficiency, and organ damage caused by graft versus host disease. In this review, we focus on early GI and liver complications following autologous (auto-) and allogeneic (allo-) HSCT and clarify both the risk factors and therapeutic strategies. Early GI and liver complications associated with HSCT remain challenging issues. Despite the improvements in this field during the last decade, treatments for these complications still place a significant burden on both patients and the physicians treating these patients. GI and liver complications remain some of the causes of mortality associated with HSCT. For practicing hematologists, oncologists, and gastroenterologists in this field, the awareness and early diagnosis of the GI complications remain important factors to obtain optimal outcomes in this patient population.tr_TR
dc.language.isoentr_TR
dc.relation.isversionof10.5152/tjg.2018.18156tr_TR
dc.subjectearly gastrointestinaltr_TR
dc.titleCurrent approach to early gastrointestinal and liver complications of hematopoietic stem cell transplantationtr_TR
dc.typeArticletr_TR
dc.relation.journalTurk J Gastroenterol .tr_TR
dc.contributor.departmentTıp Fakültesitr_TR
dc.identifier.volume30tr_TR
dc.identifier.issue2tr_TR
dc.identifier.startpage122tr_TR
dc.identifier.endpage131tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıtr_TR
dc.description.indexPubmed


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster